Login
$BLLN
$96.50 +$0.19 (0.2%) After hours

$BLLN 4 SEC Filings

Filed On Filing
12 Nov 2026 Form 4: Kolluri Krishna Kittu, Director

Disposed of 505,925 shares (Other Transaction) · Acquired 108,433 shares (Other Transaction)

10 Nov 2026 Form 4: Ileri Firat, Director

Gave up 436 shares to cover exercise price or tax ($49.7K)

04 Nov 2026 Form 4: ten Bosch John Roderick, SVP of Laboratory Operations

Sold 2,834 shares ($321K)

04 Nov 2026 Form 4: Atay Oguzhan, Director

Received 25,001 shares by exercise or conversion ($70K) · Sold 30,335 shares ($3.33M)

04 Nov 2026 Form 4: Tsao David, Director

Received 20,000 shares by exercise or conversion ($56K) · Sold 20,000 shares ($2.18M)

30 Oct 2026 Form 4: Atay Oguzhan, Director

Received 8,333 shares by exercise or conversion ($23.3K) · Sold 11,000 shares ($1.3M)

19 Oct 2026 Form 4: Lynch Thomas P., See Remarks

Received 2,000 shares by exercise or conversion ($17.3K)

16 Oct 2026 Form 4: Atay Oguzhan, Director

Received 3,183 shares by exercise or conversion ($8.91K) · Sold 5,850 shares ($574K) · Received 5,150 shares by exercise or conversion ($14.4K) · 1 more

14 Oct 2026 Form 4: Atay Oguzhan, Director

Received 16,667 shares by exercise or conversion ($46.7K) · Sold 19,334 shares ($1.82M)

13 Oct 2026 Form 4: Lynch Thomas P., See Remarks

Received 8,000 shares by exercise or conversion ($69.2K)

07 Oct 2026 Form 4: ten Bosch John Roderick, SVP of Laboratory Operations

Sold 2,834 shares ($298K)

07 Oct 2026 Form 4: Tsao David, Director

Received 20,000 shares by exercise or conversion ($56K) · Sold 20,000 shares ($2.16M)

30 Sep 2026 Form 4: Atay Oguzhan, Director

Received 8,333 shares by exercise or conversion ($23.3K) · Sold 10,999 shares ($1.33M)

28 Sep 2026 Form 4: Tsao David, Director

Received 3,333 shares by exercise or conversion ($9.33K) · Sold 3,333 shares ($417K)

28 Sep 2026 Form 4: ten Bosch John Roderick, SVP of Laboratory Operations

Sold 1,416 shares ($170K)

23 Sep 2026 Form 4: ten Bosch John Roderick, SVP of Laboratory Operations

Sold 1,416 shares ($151K)

21 Sep 2026 Form 4: Lynch Thomas P., See Remarks

Received 35,112 shares by exercise or conversion ($478K) · Sold 35,112 shares ($3.87M)

16 Sep 2026 Form 4: Atay Oguzhan, Director

Received 24,999 shares by exercise or conversion ($70K) · Sold 30,331 shares ($3.03M)

14 Sep 2026 Form 4: Sakakibara Shan Riku, Chief Product Officer

Gave 3,500 shares as a gift

11 Sep 2026 Form 4: ten Bosch John Roderick, SVP of Laboratory Operations

Sold 1,416 shares ($138K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support